eCOA

Clinical ink's eCOA solution is an electronic Clinical Outcome Assessment platform built for sites, sponsors, and CROs seeking smarter, faster, and higher-quality data collection in clinical trials. Rooted in years of traditional research, patient-centric research, and user experience expertise, Clinical ink's eCOA is core to its broader eSource technology and is designed to overcome the common shortcomings of traditional eCOA platforms — including complex workflows, inaccurate data capture, and poor patient engagement that leads to study dropout.

The platform supports a full range of validated eCOA and ePRO questionnaires across a wide range of therapeutic areas and all phases of clinical trials, deployable both onsite and remotely. It enables real-time data capture, reduces transcription errors, improves patient compliance, and streamlines data management for all stakeholders involved in clinical research.

Key Platform Advantages

• Faster Study Builder: Select any activity from an extensive eCOA library and build activities once to deploy them across multiple modalities, saving significant configuration time.
• Patient Partner (BYOD Support): Clinical ink supports Bring Your Own Device (BYOD), enabling patients to use their existing or preferred devices. Automated alerts keep patients engaged and data up-to-date, eliminating the need for additional hardware provisioning.
• Smarter Single Sign-On (SSO): A built-in SSO capability simplifies access by allowing users to log in with their existing credentials, reducing friction for both patients and site staff.
• Patient Web Portal: Patients are empowered with access to a secure, easy-to-navigate online portal — available on both desktop and mobile — for completing all eCOA activities.
• Live Translation Manager: All translations can be managed in one place, in real-time, using the integrated Translation Manager tool.
• Activity Designer: eCOA activities can be created and customized using a simple drag-and-drop interface, with a built-in eCOA Simulator allowing teams to preview assessments as they are built.

Types of Data Collected with eCOA

• Patient-reported symptoms and pain intensity
• Quality of life assessments
• Adherence to treatment
• Patient diaries
• Objective measurements from connected wearable biosensors, activity trackers, and other medical devices
• Vital signs and other real-time health monitoring data via integrated connected sensors and devices

eCOA vs. Paper-Based Assessments

• Enhanced Data Accuracy: eCOA reduces transcription errors and improves overall data quality compared to paper-based methods.
• Improved Patient Compliance: Electronic reminders and user-friendly interfaces promote better patient adherence throughout the study.
• Real-Time Data Capture: Immediate access to patient-reported outcomes is enabled through real-time data collection.
• Streamlined Efficiency: Manual data entry is eliminated, reducing administrative burden and streamlining data management processes.
• Remote Monitoring: eCOA facilitates remote access, allowing efficient monitoring and data collection without requiring frequent site visits.

Best Practices for eCOA Implementation

1. Choose eCOA tools that are user-friendly and accessible to all trial participants.
2. Provide clear training and ongoing support for both patients and site staff.
3. Prioritize data security and privacy, ensuring compliance with regulations such as HIPAA.
4. Conduct regular testing and validation of eCOA systems throughout the trial lifecycle.
5. Maintain ongoing technical support to ensure smooth and uninterrupted data collection.

Clinical ink's eCOA platform supports integration with connected sensors and wearable devices, ensuring data security and regulatory compliance throughout the process. The solution is available across smartphones, tablets, and web-based portals, and Clinical ink offers personalized cost comparisons between paper COA and eCOA to help sponsors and CROs evaluate the financial benefits of transitioning to an electronic approach.